Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Cash Flow Quality Index
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A cash flow quality index. Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Cash Flow Quality Index of 4.38x as of December 2025. Operating cash flow of CN¥837.18 Million exceeds net income of CN¥191.35 Million, indicating high earnings quality where cash backs reported profits. See Anhui Huaren Health Pharmaceutical Co. L free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Cash flow quality index of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A from 2021 to 2025. Historical Cash Flow Quality Index for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 301408 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Cash Flow Quality Index by Year (2021–2025)
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A cash flow quality index by year from 2021 to 2025. Year-by-year earnings quality comparison for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A. For the full cash flow conversion analysis, see 301408 operating cash flow.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.38x | CN¥837.18 Million | CN¥191.35 Million | ▲ +5.4% |
| 2024 | 4.15x | CN¥571.76 Million | CN¥137.70 Million | ▲ +262.4% |
| 2023 | 1.15x | CN¥131.37 Million | CN¥114.67 Million | ▲ +6.0% |
| 2022 | 1.08x | CN¥173.84 Million | CN¥160.78 Million | ▼ -46.5% |
| 2021 | 2.02x | CN¥140.82 Million | CN¥69.73 Million | — |